Department of Neurology, Cambridge University Hospitals, Cambridge, UNITED KINGDOM Introduction: Lupus patients presenting with neurology symptoms continues to represent a diagnostic challenge for clinicians as the neurology may be attributable manifestation of their disease or as a result of immunosuppression. Differentiating disease flares from infection in such patients is crucial given the diametrically opposed treatment strategies however no definitive tests to distinguish flare from infection are currently widely available. This case highlights the diagnostic challenge and treatment dilemmas patients with neurological manifestations of systemic lupus erythematosus (SLE) canpresent. Case description: A 67 year old female with a history of SLE was transferred to the neurological unit of this hospital with fluctuating confusion and fevers. She presented to her local hospital nine days previously with a three day history of confusion, lethargy and fevers. On assessement in her local emergency department she was febrile (temperature 38.1) with an elevated CRP of 68 mg/dL. She received a diagnosis of urinary sepsis and was commenced on co-amoxiclav. She continued to be febrile. An MRI scan of the head revealed multiple lacunar infarcts across several vascular territories suggestive of embolic infarcts. A transthoracic echocardiogram did not note any valvular vegetations but was significant for moderate mitral regurgitation. A lumbar puncture revealed anormal white cell count of < 2, protein 1.47, glucose 1.8, paired serum glucose 5.1. The patient was transferred for further assessment and investigation. The diagnosis of SLE was made six years prior to admission, at the age of 61, following a presentation with renal and cardiac failure. Her antibody profile at that time revealed positive titres for ANA, anti-Ro and anti-dsDNA. Hypocomplementaemia was noted. A renal biopsy was significant for class IIIa lupus nephritis. During her inpatient stay she suffered three cardiac arrests resulting in a prolonged intensive care admission and the development of a critical care myopathy. She was given a diagnosis of lupus cardiomyopathy. She was commenced on high dose steroids and mycophenolate mofetil 500 mg twice daily which was subsequently increased to 2 g daily with resulting good disease control. Hydroxychloroquine was commenced but discontinued due to a rash. In December2016,oneyearpriortoadmission,duringaperiodof mycophenolate withdrawal the patient suffered an ischaemic stroke. Four months prior to admission the patient sufferedadeep vein thrombosis of the lower limb and received a three month course of rivaroxaban. On arrival at this hospital the patient was drowsy with a GCS score of 12. Examination revealed apan-systolic murmur, noperipheral stigmataof infective endocarditis, an erythematous facial rash sparing the nano-labial folds was noted, there was no livedo reticularis. Plantar reflexes were extensor bilaterally. Over the subsequent 24 hours the patient's GCS fluctuated between 9 and 12. Blood tests revealed a mildly elevated ESR of 38 mm/ hour with a significantly elevated CRP of 108 mg/dL. A serum procalcitonin was not elevated. Antibody titres for dsDNA were normal. Complement levels (C3 and C4) were normal. A lupus anticoagulant screen revealed a mildly positive anti-beta-2-glycoprotein-1 IgG with normal titres anti-beta-2-glycoprotein-1 IgM, anticardiolipin IgG and IgM and a negative lupus anticoagulant. Therapeutic low molecular weight heparin was commenced. Repeat MRI confirmed the presence new embolic ischaemic lacunar strokes. A repeat lumbar puncture revealed an elevated lymphocyte of 28, a polymorph count of 4, protein 1.08 g/dL, CSF glucose 2.1 (paired serum glucose 6.2). Antibiotics were discontinued and blood cultures taken when the patient was febrile. A transoesophageal echocardiogram was requested to assess for the presence of vegetations. A digital subtraction angiogram was requested to assess the intracranial vasculature. The patient's GCS deteriorated and they were transferred to the neurological intensive care unit. They were commenced on ceftriaxone. Despite supportive therapy on the ICU on the tenth day of admission, neuroimaging confirmed a devastating intracranial haemorrhage. The patient died on the eleventh dayof admission. Discussion: At the time of the patient's death the differential diagnosis of the patient's presentation included: cerebral lupus, anti-phospholipid syndrome, central nervous system vasculitis, infective endocarditis, Libman-Sacks endocarditis and an infective meningitis. No immunosuppression was administered whilst the aetiology of the patient's presentation was investigated. A hospital post mortem was performed to further ascertain the cause of death. Post-mortem examination revealed a florid necrotising vasculitis throughout the brain and its leptomeningeal coverings. This was associated with multiple acute and subacute infarcts and ultimately fatal intracerebral haemorrhage and haemocephalus. There is no evidence of infectious disease. Examination of the heart revealed no valvular vegetations. Cerebral lupus vasculitis is a rare manifestation of SLE (7-12% SLE post mortem studies) and is associated with a high mortality (67%). Antiphospholipid syndrome, cerebral lupus vasculopathy, infective aetiologies and Libman-Sacks endocarditis are more common causes of neurological presentations in SLE patients. Key Learning Points: A florid necrotising cerebral lupus vasculitis can occur despite normal anti-dsDNA titres and complement levels (traditional markers of lupus activity). Despite the high C-reactive peptide and modest erythrocyte sedimentation rate values observed in this patient, no evidence of an infective process was found at post mortem suggesting the elevated CRP was attributable to cerebral vasculitis Disclosure: M.D.J. Gibson: None. Introduction: Sneddon's syndrome, first described in 1965 is a rare clinical syndrome of multiple ischaemic strokes, neurological symptoms and livedo racemosa. It is thought to have an incidence of 4 per million and has an increased prevalence in females and younger adults. Our case is one of a patient with probable Sneddon's syndrome, highlighting the diagnostic challenges and therapeutic dilemma. Case description: This is acase of a43 year oldlady with acomplex medical history, currently under the care of rheumatology, renal medicine, neurology and dermatology. She initially presented to the renal clinic with loin pain and haematuria. She had then been found to have a purpuric rash and multiple joint pain symptoms for which she as referred to rheumatology in 2005. In light of the haematuria, she underwent a renal biopsy and was found to have IgA nephropathy consistent with a diagnosis of Henoch Schonlein purpura. Her other co-morbidities included a previous ventricular septal defect, repaired in childhood and recurrent migraines. Following diagnosis, she was treated with oral glucocorticoids and azathioprine. Her symptoms improved and she did not continue with immunosuppressive therapy due to side-effects. She was then monitored in the renal clinic and had nofurther rheumatology follow-up until December 2017. On this occasion, she was referred to rheumatology from the neurology team in light of recurrent episodes of limb weakness and visual disturbances with an associated widespread livedoid rash. The neurological symptoms have been ongoing for two years, but appeared to be increasing in frequency. Three years prior to this, she developed Raynaud's phenomenon affecting hands, feet, nose and ears. During the course of her illness, she was found to have a single low positive titre of cardiolipin IgM (14MPL kU/L) and also had one previously positive test for beta 2 glycoprotein 1, but subsequent testing for APS was negative. Subsequently, she presented as an acute admission to hospital, under the neurology team with headaches and transient dysphasia. An MRI was arranged and revealed a recent cortical infarct in the left parieto-occipital region, with multiple previous cortical infarcts. She was treated as a stroke secondary to possible vasculitis, in light of her younger age and initial MRI appearances. Further investigation with CT angiography did not reveal any changes to support vasculitis. Cerebrospinal fluid analysis obtained via lumbar puncture did not show any oligoclonal bands and had normal CSF protein and glucose values. Auto-immune antibody screen, including repeat antiphospholipid antibodies, ANA and ANCA and cryoglobulins were all normal. She has also had a trans-oesophageal echocardiography, which revealed a small patent foramen ovale. Skin opinion revealed that the rash was suggestive of livedo racemosa and organised a skin biopsy. The initial biopsy was unremarkable, but this will be repeated for confirmation. In light of her clinical presentation and suspicion of inflammatory disease, she was commenced on 60 mg of prednisolone. This was gradually reduced and she has now been initiated on azathioprine. She is also on antiplatelet therapy in the form of clopidogrel. Despite her immunosuppression, she continued to have symptoms of headache and fatigue but had no further focal neurological events. Discussion: The patient has a background of IgA vasculitis which is inconsistent with the findings of livedo racemose and stroke. Therefore, she is likely to have an additional diagnosis for these symptoms. The patient had other risk factors for stroke in the form of a patent foramen ovale but did not have any evidence of venous thromboembolic disease or cardiac thrombi. Multiple strokes in a younger patient and livedoid phenomenon may also indicate antiphospholipid syndrome (APS). However, despite the transient detection of antiphospholipid antibodies at low tires in the past, this was considered insufficient for a diagnosis of APS. She also didnot have anyother features tosuggestAPS suchasrecurrentmiscarriages or venous thromboembolic disease. The combination of multiple strokes and livedo racemosa is suggestive of Sneddon's syndrome. Sneddon syndrome is thought to be associated with APS, but unlike APS is not always found to have positive antiphospholid antibodies. In the case of this patient, the initial skin biopsy was negative. The livedoid rash appeared tochangeveryrapidly making identification of asuitablebiopsy site difficult. Previous studies suggest multiple biopsies can increase sensitivity and this may be reflected in this case. Due to the relatively small number of patients with this condition, evidence for optimal management of these patients is limited. However there appearsto bea role for anticoagulation/antiplatelet therapy and immunosuppression in more resistant cases. Literature suggests a role for steroid therapy and cyclophosphamide. Azathioprinehasalso beenusedinsomecaseswith varyingresults. Although the patient did not achieve complete resolution of symptoms, the absence of any further ischaemic events may suggest a response to immunosuppressive therapy. Key Learning Points: Sneddon's syndrome is arare conditionof multiple strokes and livedo racemosa. It is often associated with antiphospholipid antibodies and may be seen in anti-phospholipid syndrome. Skin biopsy can be useful in diagnoses, but multiple biopsies may be required to increase sensitivity. Treatment primarily involves antiplatelet therapy or anticoagulation. But somecases have been found to respondto immunosuppressiveagents. Disclosure: H. Anver: None. S. Dubey: None. S. Banerjee: None. T. Potter:None. A. Short: None. A. Ilchyshyn: None.
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